Transcend Capital Advisors LLC Purchases 85 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Transcend Capital Advisors LLC lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 6.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,310 shares of the company’s stock after acquiring an additional 85 shares during the period. Transcend Capital Advisors LLC’s holdings in HCA Healthcare were worth $393,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HCA. FMR LLC grew its stake in shares of HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after buying an additional 476,756 shares during the last quarter. Meritage Group LP purchased a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $150,548,000. Canoe Financial LP grew its stake in shares of HCA Healthcare by 226,952.9% in the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after buying an additional 231,492 shares during the last quarter. Finally, Holocene Advisors LP grew its stake in shares of HCA Healthcare by 210.6% in the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after buying an additional 208,015 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $316.07 on Monday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock’s fifty day moving average is $313.53 and its 200 day moving average is $350.82. The stock has a market cap of $78.49 billion, a P/E ratio of 14.39, a P/E/G ratio of 1.10 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.